Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib

References

• DetryBBruyereFErpicumCDigging deeper into lymphatic vessel formation in vitro and in vivoBMC Cell Biol201112 2921702933
   PubMedGoogle Scholar
• JussilaLAlitaloKVascular growth factors and lymphangiogenesisPhysiol Rev2002823 673 70012087132
   PubMed Web of Science ®Google Scholar
• AvraamidesCJGarmy-SusiniBVarnerJAIntegrins in angiogenesis and lymphangiogenesisNat Rev Cancer200888 604 61718497750
   PubMed Web of Science ®Google Scholar
• PaupertJSounniNENoëlALymphangiogenesis in post-natal tissue remodeling: lymphatic endothelial cell connection with its environmentMol Aspects Med2011322 146 15821549745
   PubMed Web of Science ®Google Scholar
• CursiefenCChenLBorgesLPVEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitmentJ Clin Invest20041137 1040 105015057311
   PubMed Web of Science ®Google Scholar
• HajrasoulihaARFunakiTSadraiZHattoriTChauhanSKDanaRVascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesisInvest Ophthalmol Vis Sci2012533 1244 125022281820
   PubMed Web of Science ®Google Scholar
• ChangLKGarcia-CardeñaGFarneboFDose-dependent response of FGF-2 for lymphangiogenesisProc Natl Acad Sci U S A200410132 11658 1166315289610
   PubMed Web of Science ®Google Scholar
• CaoYDirect role of PDGF-BB in lymphangiogenesis and lymphatic metastasisCell Cycle200542 228 23015655347
   PubMed Web of Science ®Google Scholar
• KarkkainenMJHaikoPSainioKVascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veinsNat Immunol200451 74 8014634646
   PubMed Web of Science ®Google Scholar
• Al-RawiMAAJiangWGLymphangiogenesis and cancer metastasisFront Biosci201116 723 739
   Web of Science ®Google Scholar
• TzengHEChangACTsaiCHWangSWTangCHBasic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cellsOncotarget2016725 38566 3857827229532
   PubMedGoogle Scholar
• CaoRBjörndahlMAReligaPPDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasisCancer Cell200464 333 34515488757
   PubMed Web of Science ®Google Scholar
• CaoYZhongWTumor-derived lymphangiogenic factors and lymphatic metastasisBiomed Pharmacother2007619 534 53917904785
   PubMed Web of Science ®Google Scholar
• Van der AuweraICaoYTilleJCFirst international consensus on the methodology of lymphangiogenesis quantification in solid human tumoursBr J Cancer20069512 1611 162517117184
   PubMed Web of Science ®Google Scholar
• ChenLOcular lymphatics: state-of-the-art reviewLymphology2009422 66 7619725271
   PubMed Web of Science ®Google Scholar
• AlitaloKTammelaTPetrovaTVLymphangiogenesis in development and human diseaseNature20054387070 946 95316355212
   PubMed Web of Science ®Google Scholar
• CueniLNDetmarMThe lymphatic system in health and diseaseLymphat Res Biol200863–4 109 12219093783
   PubMedGoogle Scholar
• HilbergFRothGJKrssakMBIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacyCancer Res20086812 4774 478218559524
   PubMed Web of Science ®Google Scholar
• Kutluk CenikBOstapoffKTGerberDEBrekkenRABIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancerMol Cancer Ther2013126 992 100123729403
   PubMed Web of Science ®Google Scholar
• MrossKStefanicMGmehlingDPhase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumorsClin Cancer Res2010161 311 31920028771
   PubMed Web of Science ®Google Scholar
• ReckMKaiserREschbachCA phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancerAnn Oncol2011226 1374 138121212157
   PubMed Web of Science ®Google Scholar
• LedermannJAHackshawAKayeSRandomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancerJ Clin Oncol20112928 3798 380421859991
   PubMed Web of Science ®Google Scholar
• RiveraJCNoueihedBOmriSBarruecoJHilbergFChemtobSBIBF1120 (Vargatef) inhibits preretinal neovascularization and enhances normal vascularization in a model of vasoproliferative retinopathyInvest Ophthalmol Vis Sci20155613 7897 790726670826
   PubMed Web of Science ®Google Scholar
• AguilarBChoiIChoiDLymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptorCancer Res20127222 5833 584222942256
   PubMed Web of Science ®Google Scholar
• DingDWeiSSongYOsthole exhibits anti-cancer property in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathwaysCell Physiol Biochem2013326 1751 176024356539
   PubMedGoogle Scholar
• MinJKChoYLChoiJHReceptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient miceBlood20071094 1495 150217038532
   PubMed Web of Science ®Google Scholar
• TruongTHuangEYuenDChenLCorneal lymphatic valve formation in relation to lymphangiogenesisInvest Ophthalmol Vis Sci2014553 1876 188324595382
   PubMed Web of Science ®Google Scholar
• AndersonCZhouQWangSAn alkali-burn injury model of corneal neovascularization in the mouseJ Vis Exp201486 51159
   Google Scholar
• KojimaTChangJHAzarDTProangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesisAm J Pathol20071702 764 77317255342
   PubMed Web of Science ®Google Scholar
• FerraraNHillanKJGerberHPNovotnyWDiscovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNat Rev Drug Discov200435 391 40015136787
   PubMed Web of Science ®Google Scholar
• ErberRThurnherAKatsenADCombined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanismsFASEB J2004182 338 34014657001
   PubMed Web of Science ®Google Scholar
• BergersGSongSMeyer-MorseNBergslandEHanahanDBenefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsJ Clin Invest20031119 1287 129512727920
   PubMed Web of Science ®Google Scholar
• CasanovasOHicklinDJBergersGHanahanDDrug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsCancer Cell200584 299 30916226705
   PubMed Web of Science ®Google Scholar
• SantosESGomezJERaezLETargeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitorInvest New Drugs2012303 1261 126921350804
   PubMed Web of Science ®Google Scholar
• CaglevicCGrassiMRaezLNintedanib in non–small cell lung cancer: from preclinical to approvalTher Adv Respir Dis201594 164 17225855060
   PubMed Web of Science ®Google Scholar
• RothGJBinderRColbatzkyFNintedanib: from discovery to the clinicJ Med Chem2015583 1053 106325474320
   PubMed Web of Science ®Google Scholar
• du BoisAKristensenGRay-CoquardIAGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup ConsortiumStandard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trialLancet Oncol2016171 78 8926590673
   PubMed Web of Science ®Google Scholar
• Garmy-SusiniBAvraamidesCJSchmidMCIntegrin alpha4-beta1 signaling is required for lymphangiogenesis and tumor metastasisCancer Res2010708 3042 305120388801
   PubMed Web of Science ®Google Scholar
• CaoZShangBZhangGTumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasisBiochim Biophys Acta201318362 273 28623933263
   PubMed Web of Science ®Google Scholar
• HirakawaSBrownLFKodamaSPaavonenKAlitaloKDetmarMVEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sitesBlood20071093 1010 101717032920
   PubMed Web of Science ®Google Scholar
• CaoRJiHFengNCollaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasisProc Natl Acad Sci U S A201210939 15894 1589922967508
   PubMed Web of Science ®Google Scholar
• KatherJNKrollJTransgenic mouse models of corneal neovascularization: new perspectives for angiogenesis researchInvest Ophthalmol Vis Sci20145511 7637 765125425566
   PubMed Web of Science ®Google Scholar
• EllenbergDAzarDTHallakJANovel aspects of corneal angiogenic and lymphangiogenic privilegeProg Retin Eye Res2010293 208 24820100589
   PubMed Web of Science ®Google Scholar
• KerjaschkiDHuttaryNRaabILymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplantsNat Med2006122 230 23416415878
   PubMed Web of Science ®Google Scholar
• YamamotoIYamaguchiYYamamotoHA pathological analysis of lymphatic vessels in early renal allograftTransplant Proc20063810 3300 330317175254
   PubMed Web of Science ®Google Scholar
• DietrichTBockFYuenDCutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantationJ Immunol20101842 535 53920018627
   PubMed Web of Science ®Google Scholar
• TangXLSunJFWangXYDuLLLiuPBlocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized bedsMol Vis201016 2354 236121139694
   PubMed Web of Science ®Google Scholar
• ZhangHGrimaldoSYuenDChenLCombined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survivalInvest Ophthalmol Vis Sci2011529 6529 653521715348
   PubMed Web of Science ®Google Scholar
• HosDBockFDietrichTInflammatory corneal (lymph)angio-genesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantationInvest Ophthalmol Vis Sci2008495 1836 184218436817
   PubMed Web of Science ®Google Scholar
• DetryBBlacherSErpicumCSunitinib inhibits inflammatory corneal lymphangiogenesisInvest Ophthalmol Vis Sci2013545 3082 309323580490
   PubMed Web of Science ®Google Scholar
• GordonEJRaoSPollardJWNuttSLLangRAHarveyNLMacrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferationDevelopment201013722 3899 391020978081
   PubMed Web of Science ®Google Scholar
• MaruyamaKIiMCursiefenCInflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophagesJ Clin Invest20051159 2363 237216138190
   PubMed Web of Science ®Google Scholar
• NichollsSMMitchardLKLaycockGMA model of corneal graft rejection in semi-inbred NIH miniature swine: significant T-cell infiltration of clinically accepted allograftsInvest Ophthalmol Vis Sci2012536 3183 319222467584
   PubMedGoogle Scholar
• TanYCruz-GuillotyFMedina-MendezCAImmunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejectionJ Immunol201218812 5962 596922593618
   PubMed Web of Science ®Google Scholar
• TanYAbdulredaMHCruz-GuillotyFRole of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejectionAm J Transplant2013136 1461 147323679575
   PubMed Web of Science ®Google Scholar
• BorhaniDWCalderwoodDJFriedmanMMA-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejectionBioorg Med Chem Lett20041410 2613 261615109663
   PubMed Web of Science ®Google Scholar
• StachlewitzRFHartMABettencourtBA-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejectionJ Pharmacol Exp Ther20053151 36 4116014572
   PubMed Web of Science ®Google Scholar
• BurchatABorhaniDWCalderwoodDJHirstGCLiBStachlewitzRFDiscovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejectionBioorg Med Chem Lett2006161 118 12216216497
   PubMed Web of Science ®Google Scholar
• ZhouQYangLQuMRole of senescent fibroblasts on alkali-induced corneal neovascularizationJ Cell Physiol20122273 1148 115621567404
   PubMed Web of Science ®Google Scholar
• HanKYFahdDCTshionyiMMT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblastsProtein Pept Lett20121912 1334 133922670674
   PubMed Web of Science ®Google Scholar
• HostettlerKEZhongJPapakonstantinouEAnti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosisRespir Res201415 15725496490
   PubMed Web of Science ®Google Scholar
• HuangJBeyerCPalumbo-ZerrKNintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosisAnn Rheum Dis2016755 883 89025858641
   PubMed Web of Science ®Google Scholar
• KarpanenTAlitaloKMolecular biology and pathology of lymphangiogenesisAnnu Rev Pathol20083 367 39718039141
   PubMed Web of Science ®Google Scholar